Ознакомительная версия.
12 Kalish M. et al. Central African hunters exposed to Simian immunodefciency virus // Emerging Infectious Diseases, 2005 Dec., Vol. 11(12), 1928–1930.
13 Gilbert T. et al. The emergence of HIV/AIDS in the Americas and beyond // PNAS, 2007, Vol. 104, No. 47, 18566– 18570.
14 Пиневич А. В., Сироткин А. К., Гаврилова О. В., Потехин А. А. Вирусология: учебник. СПб.: Издательство Санкт-Петербургского университета, 2012. 432 с.
15 Ярилин А. А. Иммунология: учебник. М.: ГЭОТАР-Медиа, 2010. 752 с.
16 Атлас по медицинской микробиологии, вирусологии и иммунологии: Учебное пособие для студентов медицинских вузов / под ред. А. А. Воробьева, А. С. Быкова. М.: Медицинское информационное агентство, 2003. 236 с.
17 Doitsh G. et al. Cell death by pyroptosis drives CD4 T– cell depletion in HIV-1 infection // Nature, Jan. 2014, Vol. 505, 509–514.
18 The Durban Declaration // Nature, July 2000, Vol. 406, 15–16. Доступна по ссылке: http://www.nature.com/nature/journal/ v406/n6791/full/406015a0.html
19 De Clercq, E. The history of antiretrovirals: key discoveries over the past 25 years // Reviews in Medical Virology, Sep. 2009, Vol. 19, Issue 5, 287–299.
20 Volberding P. et al. Zidovudine in asymptomatic human immunodefciency virus infection. A controlled trial in persons with fewer than 50 °CD4-positive cells per cubic millimeter // New England Journal of Medicine, 1990, Vol. 322(14), 941–949.
21 Dournon E. et al. Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex // Lancet, Dec. 1988, Vol. 332, No. 8623, 1297–1302.
22 Connor E. et al. Reduction of maternal-infant transmission of human immunodefciency virus type 1 with zidovu-dine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group // New England Journal of Medicine, Nov. 1994, 3; Vol. 331(18), 1173–1180.
23 Larder B, Kemp A. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT) // Science, Dec. 1989: Vol. 246, No. 4934, 1155–1158.
24 Hammer S. et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodefcien-cy virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team // New England Journal of Medicine, 1997, Sep. 11, Vol. 337(11), 725–733.
25 Gulick R. et al. Treatment with Indinavir, Zidovudine, and Lamivudine in adults with human immunodefciency virus infection and prior antiretroviral therapy // New England Journal of Medicine, 1997, Vol. 337, 734–739.
26 Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies // Lancet, 2008, Vol. 372, 293–299.
27 Weller S., Davis K. Condom effectiveness in reducing heterosexual HIV transmission // The Cochrane Database of Systematic Reviews, 2002.
28 Townsend C. et al. Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011 // AIDS, Apr. 2014, Vol. 28, Issue 7, 1049–1057.
29 Коалиция по готовности к лечению. Закупки АРВ-препаратов в 2014 году: хроника децентрализации. Результаты мониторинга закупок и предоставления АРВ-препаратов в РФ. Санкт-Петербург, 2015. Публикация доступна на сайте http://itpcru.org
30 Hutter G. et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation // New England Journal of Medicine, Feb. 2009, Vol. 360, 692–698.
31 Hutter G., Thiel E. Allogeneic transplantation of CCR5-defcient progenitor cells in a patient with HIV infection: An update after 3 years and the search for patient no. 2 // AIDS, Jan. 2011, Vol. 25, Issue 2, 273–274.
32 Yukl S. et al. Challenges in detecting HIV persistence during potentially curative interventions: A study of the Berlin patient // PLOS Pathogens, May 2013, Vol. 9(5), e1003347.
33 Brown T. I am the Berlin patient: A personal refection // AIDS Research and Human Retroviruses, Jan. 2015, Vol. 31, No. 1, 2–3.
34 Poropatich K., Sullivan D. Human immunodefciency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression // Journal of General Virology, February 2011, Vol. 92, No. 2, 247–268.
35 Saez-Cirion A. et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI study // PLOS Pathogens, Mar. 2013, Vol. 9(3), e1003211.
36 Lehrman G., Hogue I. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study // Lancet, Aug. 2005, Vol. 366(9485), 549–555.
37 Tebas P. et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV // New England Journal of Medicine, 2014, Vol. 370, 901–910.
38 Caskey M. et al. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117 // Nature, June 2015, Vol. 522, 487–491.
39 Hu W. et al. RNA-directed gene editing specifcally eradicates latent and prevents new HIV-1 infection // PNAS, July 2014, Vol. 111, No. 31, 11461–11466.
40 Hammer S. et al. Effcacy trial of a DNA/rAd5 HIV-1 preventive vaccine // New England Journal of Medicine, 2013, Nov. 28, Vol. 369(22), 2083–2092.
41 Rerks-Ngarm S. et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand // New England Journal of Medicine, 2009, Vol. 361, 2209–2220.
42 Dosenovic P. et al. Immunization for HIV-1 broadly neutralizing antibodies in human Ig knockin mice // Cell, 2015, June 18, Vol. 161, Issue 7, 1505–1515.
43 Jardine J. et al. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen // Science, July 2015, Vol. 349, No. 6244, 156–161.
44 Sanders R. et al. HIV-1 neutralizing antibodies induced by native-like envelope trimers // Science, July 2015, Vol. 349, No. 6244, aac4223.
Глава 4. “Акупунктура – серьезный метод лечения”
1 Статья, которую начальство не разрешило мне опубликовать в журнале “Здоровье”, теперь выпадает второй ссылкой на запрос “акупунктура” в гугле, что заставляет меня слегка злорадствовать. Она доступна либо на сайте “Популярной механики”, либо в ЖЖ автора (комменты жгут): http://www.popmech.ru/science/56978-akupunktura-lechit-ili-kalechit/, http://scinquisitor.livejournal.com/62796.html
2 Тыкочинская Э. Д. Основы иглорефлексотерапии. М.: Медицина, 1979. 344 с.
3 Самосюк И. З. и др. Научные основы акупунктуры // Фізіологічний журнал НАН України, 2003, № 2.
4 Яроцкая Э. П. Рефлексотерапия заболеваний внутренних органов. Х.: Дельта, 1994. 160 с.
5 Plummer J. Anatomical fndings at acupuncture loci // American Journal of Chinese Medicine, 1980, Vol. 8, No. 2, 170–180.
6 Lucas N. et al. Reliability of physical examination for diagnosis of myofascial trigger points: a systematic review of the literature // Clin. J. Pain., 2009 Jan, Vol. 25(1), 80–89.
7 Ahn A. et al. Electrical properties of acupuncture points and meridians: a systematic review // Bioelectromagnetics, 2008, Vol. 29, 245–256.
8 Cheng K. Neurobiological mechanisms of acupuncture for some common illnesses: a clinician’s perspective // Journal of Acupuncture and Meridian Studies, 2014 June, Vol. 7(3), 105–114.
9 Scott W., Scott N. A biochemical hypothesis for the effectiveness of acupuncture in the treatment of substance abuse: Acupuncture and the reward cascade //American Journal of Acupuncture, 1997, Vol. 25, 33–40.
10 Kendall D. A scientifc model of acupuncture, parts 1 & 2 // American Journal of Acupuncture, 1989; 17(3): 251–268; 17(4): 343–360” – вот все, что известно о статье про выделение серотонина, которую невозможно найти.
11 Yoshimoto K. et al. Acupuncture stimulates the release of serotonin, but not dopamine, in the rat nucleus accum-bens // Tohoku Journal of Experimental Medicine, 2006 Apr. Vol. 208(4), 321–326.
12 Moffet H. Sham acupuncture may be as effcacious as true acupuncture: a systematic review of clinical trials //Jo u r – nal of Alternative and Complementary Medicine, 2009 Mar, Vol. 15(3), 213–216.
13 Manyanga T. et al. Pain management with acupuncture in osteoarthritis: a systematic review and meta-analysis // BMC Complementary and Alternative Medicine, 2014, Vol. 14, 312.
14 Vickers A. et al. Acupuncture for chronic pain: individual patient data meta-analysis // Archives of Internal Medicine, 2012, Oct. 22, Vol. 172(19), 1444–1453.
15 Madsen M. et al. Acupuncture treatment for pain: systematic review of randomised clinical trials with acupuncture, placebo acupuncture, and no acupuncture groups // BMJ, 2009, Jan. 27, Vol. 338, a3115.
16 Ernst E. Acupuncture: What does the most reliable evidence tell us? // Journal of Pain and Symptom Management, April 2009, Vol. 37, Issue 4, 709–714.
17 White P. et al. Practice, practitioner, or placebo? A multi-factorial, mixed-methods randomized controlled trial of acupuncture // Pain, 2012, Vol. 153, 455–462.
18 Ernst E. et al. Acupuncture: Does it alleviate pain and are there serious risks? A review of reviews // Pain, 2011, Vol. 152, 755–764.
19 Chang S et al. Aortoduodenal fstula complicated by acupuncture // International Journal of Cardiology, 2005, Sep. 30, Vol. 104(2), 241–242.
Глава 5. “ГМО содержат гены!”
1 Статистические данные ИСИЭЗ НИУ ВШЭ: http://www. hse.ru/monitoring/innpeople/inp1 (в т. ч. см. pdf-документ, который можно скачать по ссылке с этой страницы).
2 Griffith F. The signifcance of pneumococcal types // The Journal of Hygiene (Lond.), 1928 Jan. Vol. 27(2), 113–159.
3 Mandel M., Higa A. Calcium-dependent bacteriophage DNA infection // The Journal of Molecular Biology, Oct. 1970, Vol. 53, Issue 1, 159–162.
4 Cohen S. et al. Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA // PNAS, Aug. 1972, Vol. 69, No. 8, 2110–2114.
5 Jackson D. et al. Biochemical method for inserting new genetic information into DNA of Simian virus 40: Circular SV40 DNA molecules containing lambda phage genes and the galactose operon of Escherichia coli // PNAS, Oct. 1972, Vol. 69, No. 10, 2904–2909.
6 Cohen S. et al. Construction of biologically functional bacterial plasmids in vitro // PNAS, Nov. 1973, Vol. 70, No. 11, 3240–3244.
7 Статистика сайта gmo-compass.org, поддерживаемого независимой командой ученых и научных журналистов. Мне хотелось на него где-нибудь сослаться, потому что это вообще хорошая база данных по ГМ-растениям, используемым в Европе (еще одна хорошая база данных по ГМ-растениям, используемым в мире, есть на сайте isaaa.org).
8 Berg P. et al. Summary statement of the Asilomar Conference on recombinant DNA molecules // PNAS, June 1975, Vol. 72, No. 6, 1981–1984.
9 Watson J.D. In Defense of DNA. 1976 Annual Report, Cold Spring Harbor Laboratory, цитирую по статье на сайте FDA, посвященной двадцатипятилетию трансгенного инсулина: http://www.fda.gov/AboutFDA/WhatWeDo/ History/ProductRegulation/SelectionsFromFDLIUpdate-SeriesonFDAHistory/ucm081964.htm#ftn7
10 Инге-Вечтомов С. Г. Генетика с основами селекции: учебник для студентов высших учебных заведений. 2-е издание, перераб. и доп. СПб.: Изд-во Н-Л, 2010. 720 с.
11 National Research Council (US) Commission on Life Sciences. Biotechnology and the Food Supply: Proceedings of a Symposium. Washington (DC): National Academies Press (US); 1988. Potential food safety problems related to new uses of biotechnolo-g y. Текст доступен по ссылке: http://www.ncbi.nlm.nih.gov/books/NBK235027/
12 Cohen S. Recombinant DNA: Fact and fction // Western Journal of Medicine, May 1977, Vol. 126, 415–420 (Reprinted from Science, Feb. 1977, Vol. 195, 654–657).
13 Ye X. et al. Engineering the provitamin A (beta-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm // Science, 2000, Jan. 14, Vol. 287(5451), 303–305.
14 Paine J. et al. Improving the nutritional value of Golden Rice through increased pro-vitamin A content // Nature Biotechnology, Mar. 2005, Vol. 23, 482–487.
15 Данные по дефициту витамина А и его последствиям от ВОЗ: http://www.who.int/nutrition/topics/vad/en/
16 Harrigan G. et al. The forage and grain of MON 87460, a drought-tolerant corn hybrid, are compositionally equivalent to that of conventional corn // Journal of Agricultural and Food Chemistry, Sep. 2009, Vol. 57, 9754–9763.
17 Sammons B. et al. Characterization of drought-tolerant maize MON 87460 for use in environmental risk assessment // Crop Science, Mar-Apr 2014, Vol. 54, 719–729.
Ознакомительная версия.
